NCT05970744 Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years Status COMPLETED Phase PHASE1
NCT05970510 A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder. Status RECRUITING Phase PHASE3
NCT05969977 A First-in-Human Phase 1 Study of Plasmalogen Precursor PPI-1011 in Healthy Adult Volunteers to Assess Safety, Tolerability, and Pharmacokinetics Status UNKNOWN Phase PHASE1
NCT05969236 A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults Status COMPLETED Phase PHASE1
NCT05969119 Addition of Pyridostigmine to Conventional Management of Postdural Puncture Headache Status COMPLETED Phase PHASE4
NCT05968430 Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05968118 Angiogenesis and Blood Perfusion Effect of HGF Gene Therapy in PAD Patients Status UNKNOWN Phase PHASE3
NCT05967520 JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus Status RECRUITING Phase PHASE2
NCT05967052 Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation Status RECRUITING Phase PHASE2
NCT05966480 Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05966064 DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD) Status RECRUITING Phase PHASE4
NCT05965414 Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers Status COMPLETED Phase EARLY_PHASE1
NCT05965089 A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis. Status COMPLETED Phase PHASE1
NCT05964790 Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia Status UNKNOWN Phase PHASE1/PHASE2
NCT05964413 Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum Status TERMINATED Phase PHASE3
NCT05963022 A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO) Status COMPLETED Phase PHASE3
NCT05962606 Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia. Status COMPLETED Phase PHASE2